Skip to content
Business

Allianz Posts a Record €14.1bn Nine-Month Profit and Raises Its 2026 Outlook

Allianz lifted the top of its 2026 operating profit range to about €18.6bn after a record €14.1bn for nine months, up 7.8%, as asset management profit jumped 35% in the third quarter.

The Allianz office campus in Unterföhring near Munich, white buildings with the Allianz logo on the roof behind a field.
Photo: Florian Hurlbrink / Wikimedia Commons, CC BY-SA 4.0

Allianz raised the top of its 2026 operating profit target to about €18.6bn on Thursday after a record €14.1bn for the first nine months, up 7.8%. Third-quarter operating profit rose 6.2% to €4.7bn as profit in asset management jumped 35%, which more than made up for a weaker quarter in property-casualty insurance.

The results reach a stock that has been climbing. Allianz closed last week at €451.10, its highest weekly close since late August, after gains of 2.52% and 2.83% in the two previous weeks. It had slid to a weekly close of €416.20 on 2 October.

Allianz in numbers

  • €14.1bn nine-month operating profit, a record, +7.8%
  • +35.1% asset management operating profit in the third quarter
  • 219% Solvency II capital ratio at 30 September

Asset Management Carries the Quarter

SegmentQ3 operating profitChange
Property-Casualty€2,204m-7.9%
Life/Health€1,469m+4.4%
Asset Management€1,119m+35.1%
Group€4,709m+6.2%

Asset management, which includes PIMCO and Allianz Global Investors, did the heavy lifting. Operating revenues rose 21.6% on an internal basis to €2.6bn, and the cost-income ratio improved by 4.0 points to 56.3%. Third-party assets under management reached €2,152bn at the end of September, up from €1,990bn at the end of 2025.

Clients added €47bn of net new money in the quarter, 8.3% less than a year earlier. Over nine months net inflows were €132bn, up 40.4%, and asset management operating profit rose 20.3% to €2.9bn.

Total business volume for the group was €44.4bn in the quarter, up 3.0% on an internal basis, and €143.0bn for nine months.

Allianz: share price, chart and news

Allianz chief executive Oliver Bäte speaking at a lectern bearing the Allianz logo at the 2025 annual general meeting.
Allianz chief executive Oliver Bäte speaking at a lectern bearing the Allianz logo at the 2025 annual general meeting. Photo: MsBlix / Wikimedia Commons, CC BY-SA 4.0

A Tougher Quarter in Property-Casualty

Property-casualty business volume grew 4.5% on an internal basis to €20.9bn, but operating profit fell 7.9% to €2.2bn. The combined ratio, claims and costs as a share of premiums, rose 2.0 points to 93.8%, with a loss ratio of 70.6%. Over nine months the combined ratio was 92.2%, and segment operating profit was still up 3.2% at €7.1bn.

Life/Health operating profit rose 4.4% to €1.47bn. The value of new business slipped 0.6% to €1.04bn and the new business margin eased to 5.6%, from 5.9%. The contractual service margin, the stock of profit still to be earned on existing policies, stood at €56.4bn.

Net Income Dips, Returns Stay High

Net income attributable to shareholders fell 2.2% in the quarter to €2.78bn. Shareholders' core net income rose 1.2% to €2.89bn, and core earnings per share rose 3.5% to €7.70. For nine months core EPS was up 12.7% at €24.15, and the annualised core return on equity was 20.1%, against 18.1% for 2025.

Capital remains ample. The Solvency II ratio was 219% at 30 September, against 218% at the end of 2025, and the share buyback of up to €2.5bn announced on 25 February was completed by 22 September.

Finance chief Claire-Marie Coste-Lepoutre said the record came "with all segments contributing".

The New Outlook and What Investors Watch

Allianz started the year targeting operating profit of €17.4bn, plus or minus €1bn, a range of €16.4bn to €18.4bn. It now puts the top of that range at about €18.6bn. With €14.1bn earned in nine months, the new upper end would need about €4.5bn in the fourth quarter, less than the €4.7bn earned in the third.

The insurer repeated that natural catastrophes and moves in capital markets could materially affect results, so the fourth-quarter claims bill is the main swing factor for the final figure. The property-casualty combined ratio will be the number to watch after this quarter's rise.

Capital returns are the other question. This year's buyback was announced with the 2025 results in February and is now finished, so investors will look to the full-year results for the next decision on how much of a 219% solvency ratio goes back to shareholders.

Sources

Related stories

Business

Allianz Signs Deal to Sell 30% of Allianz Greece to National Bank of Greece

Allianz and National Bank of Greece signed binding agreements for the bank to buy 30% of Allianz Greece and sell its policies exclusively from early 2027. No price was disclosed.

Business

Siemens Posts Record Orders and Free Cash Flow and Raises Its Mid-Term Targets

Siemens booked record fourth-quarter orders of €34.8bn, up 58%, and record free cash flow of €12.1bn, raised its dividend to €5.50 and lifted mid-term growth targets ahead of a…

Business

Deutsche Telekom Lifts Its Guidance and Plans a Record €1.10 Dividend

Deutsche Telekom beat third-quarter forecasts as adjusted EBITDA AL rose 8% organically to €12.2bn, lifted its 2026 goals on T-Mobile US strength and plans a 10% higher dividend of…

Business

Bayer Wins FDA Approval for Sunharbo, the First Factor XIa Blood Thinner in the US

Bayer shares rose about 1.5% to their highest since May 2023 after the FDA approved Sunharbo, the first Factor XIa blood thinner in the US, which cut repeat strokes by 26% in its…

Business

Québecor Makes a C$31bn Cash-and-Share Bid for Telus, Which Warns of Regulatory Risk

Québecor has offered C$6.35 in cash plus 0.17 of its own shares for each Telus share, a bid worth about C$31bn. The Telus board says the price falls short and the regulatory risk…

Business

Tyson Foods Shares Jump 8.7% as Beef Outlook Outweighs a $74m Quarterly Loss

Tyson Foods posted a $74m fourth-quarter net loss and adjusted EPS of $0.61, down 47%, yet its shares closed 8.7% higher on Monday as its 2027 beef outlook pointed to far smaller…

Business

Roche Wins FDA Approval for Breast Cancer Pill Wilserdly After 62% Cut in Progression Risk

The FDA approved Roche's all-pill Wilserdly combination for ESR1-mutated advanced breast cancer after it cut the risk of progression or death by 62%. A ruling on early-stage use is…

Business

ULA Loses Its First Mission as Vulcan Rocket Fails With 40 Amazon Leo Satellites on Board

United Launch Alliance's Vulcan rocket failed about 10 minutes after lift-off on Sunday, and all 40 Amazon Leo satellites were lost. Amazon fell 3.3% on Monday as space stocks…